BRENTWOOD, Tenn.--(BUSINESS WIRE)--Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing marketing communications services to a major pharmaceutical firm for a clinical trial for patients with urinary incontinence. The study will determine the safety and effectiveness of an investigational medication in managing the symptoms of urinary incontinence caused by neurogenic detrusor overactivity in both men and women who have MS or a spinal cord injury (SCI) and have not been adequately managed with anticholinergic therapy.
